Although Bersuker [41] found that FSP1 expression was positively correlated with ferroptosis disease resistance in many cancer cell lines, the relationship between FSP1 and ferroptosis after ICH has not been thoroughly studied, so upregulating FSP1 may be a promising research direction for inhibiting ferroptosis after ICH. Here, AIFM2 is linked to cancer.